Back to Search
Start Over
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
- Source :
- Neurology: official journal of the American Academy of Neurology 88(14), 1321-1328 (2017). doi:10.1212/WNL.0000000000003789, Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid, Consejería de Sanidad de la Comunidad de Madrid, Neurology
- Publication Year :
- 2017
- Publisher :
- Wolters Kluwer, 2017.
-
Abstract
- Neurology: official journal of the American Academy of Neurology 88(14), 1321-1328 (2017). doi:10.1212/WNL.0000000000003789<br />Published by Wolters Kluwer, Philadelphia, Pa.
- Subjects :
- Adult
Lung Diseases
Male
030506 rehabilitation
Adolescent
incobotulinumtoxinA, limb spasticity
dose safety
dose efficacy
Vital signs
Article
Young Adult
03 medical and health sciences
Muscle tone
0302 clinical medicine
incobotulinumtoxinA
Humans
Medicine
Spasticity
Botulinum Toxins, Type A
Young adult
Adverse effect
Aged
Retrospective Studies
Aged, 80 and over
Dose-Response Relationship, Drug
Vital Signs
business.industry
Incidence (epidemiology)
Extremities
Retrospective cohort study
Middle Aged
3. Good health
medicine.anatomical_structure
Neuromuscular Agents
Tolerability
Muscle Spasticity
Anesthesia
Female
Neurology (clinical)
limb spasticity
medicine.symptom
0305 other medical science
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Neurology: official journal of the American Academy of Neurology 88(14), 1321-1328 (2017). doi:10.1212/WNL.0000000000003789, Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid, Consejería de Sanidad de la Comunidad de Madrid, Neurology
- Accession number :
- edsair.doi.dedup.....670144c19198fce7f94fed0a66f8941f
- Full Text :
- https://doi.org/10.1212/WNL.0000000000003789